Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems
Post-stroke depression (PSD) is the most common non-cognitive neuropsychiatric complication after stroke, and about a third of patients with stroke have depression. Although a great deal of effort has been made to treat PSD, the efficacy thereof has not been satisfactory, due to the complex patholog...
Saved in:
Main Authors: | Meng Zhang (Author), Xue Bai (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of Shugan Jieyu capsules for psychiatric symptoms of epilepsy: a systematic review and meta-analysis
by: Sejin Kim, et al.
Published: (2024) -
Antidepressant Shugan Jieyu Capsule Alters Gut Microbiota and Intestinal Microbiome Function in Rats With Chronic Unpredictable Mild Stress -Induced Depression
by: Jingxuan Tan, et al.
Published: (2022) -
Effectiveness of the Shugan Jieyu Capsule against Psychiatric Symptoms in Epilepsy: a protocol for systematic review and meta-analysis
by: Sejin Kim, et al.
Published: (2023) -
Traditional Chinese Medicine in Depression Treatment: From Molecules to Systems
by: Chan Li, et al.
Published: (2020) -
Protective effects of Zuogui Jiangtang Jieyu Formula on hippocampal neurons in rats of diabetes complicated with depression via the TRP/KYN metabolic pathway
by: Ling Jia, et al.
Published: (2022)